317 related articles for article (PubMed ID: 30654643)
1. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
Attia E; Steinglass JE; Walsh BT; Wang Y; Wu P; Schreyer C; Wildes J; Yilmaz Z; Guarda AS; Kaplan AS; Marcus MD
Am J Psychiatry; 2019 Jun; 176(6):449-456. PubMed ID: 30654643
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
Bissada H; Tasca GA; Barber AM; Bradwejn J
Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus placebo for out-patients with anorexia nervosa.
Attia E; Kaplan AS; Walsh BT; Gershkovich M; Yilmaz Z; Musante D; Wang Y
Psychol Med; 2011 Oct; 41(10):2177-82. PubMed ID: 21426603
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
Spettigue W; Buchholz A; Henderson K; Feder S; Moher D; Kourad K; Gaboury I; Norris M; Ledoux S
BMC Pediatr; 2008 Jan; 8():4. PubMed ID: 18234120
[TBL] [Abstract][Full Text] [Related]
6. Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.
Duvvuri V; Cromley T; Klabunde M; Boutelle K; Kaye WH
Int J Eat Disord; 2012 Mar; 45(2):294-7. PubMed ID: 21344468
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis.
Han R; Bian Q; Chen H
Brain Behav; 2022 Feb; 12(2):e2498. PubMed ID: 35020271
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports.
Boachie A; Goldfield GS; Spettigue W
Int J Eat Disord; 2003 Jan; 33(1):98-103. PubMed ID: 12474205
[TBL] [Abstract][Full Text] [Related]
9. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine in the treatment of anorexia nervosa: an open label trial.
Powers PS; Santana CA; Bannon YS
Int J Eat Disord; 2002 Sep; 32(2):146-54. PubMed ID: 12210656
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
Hagman J; Gralla J; Sigel E; Ellert S; Dodge M; Gardner R; O'Lonergan T; Frank G; Wamboldt MZ
J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine use in adolescent anorexia nervosa.
Dennis K; Le Grange D; Bremer J
Eat Weight Disord; 2006 Jun; 11(2):e53-6. PubMed ID: 16809970
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine treatment of anorexia nervosa: a retrospective study.
Malina A; Gaskill J; McConaha C; Frank GK; LaVia M; Scholar L; Kaye WH
Int J Eat Disord; 2003 Mar; 33(2):234-7. PubMed ID: 12616591
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion?
Brambilla F; Monteleone P; Maj M
Psychoneuroendocrinology; 2007 May; 32(4):402-6. PubMed ID: 17395395
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine therapy in anorexia nervosa: psychobiological effects.
Brambilla F; Garcia CS; Fassino S; Daga GA; Favaro A; Santonastaso P; Ramaciotti C; Bondi E; Mellado C; Borriello R; Monteleone P
Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine treatment of an adolescent girl with anorexia nervosa.
Ercan ES; Copkunol H; Cýkoethlu S; Varan A
Hum Psychopharmacol; 2003 Jul; 18(5):401-3. PubMed ID: 12858329
[TBL] [Abstract][Full Text] [Related]
18. The role of olanzapine in the treatment of anorexia nervosa.
Dunican KC; DelDotto D
Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.
Bystritsky A; Ackerman DL; Rosen RM; Vapnik T; Gorbis E; Maidment KM; Saxena S
J Clin Psychiatry; 2004 Apr; 65(4):565-8. PubMed ID: 15119922
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy.
Holtkamp K; Konrad K; Kaiser N; Ploenes Y; Heussen N; Grzella I; Herpertz-Dahlmann B
J Psychiatr Res; 2005 May; 39(3):303-10. PubMed ID: 15725429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
